Trim 15-20% to Underweight; event-driven re-entry guards against premature exit and overcalibrated bear-case selling
The 15-20% trim to Underweight represents the operationally correct calibration: it respects the asymmetric risk flagged by all three analysts (Q1 operating income down 1.4% YoY, structural 381bps gross margin collapse, heroic EPS path assumptions, broken technicals at 4.1% below 50 SMA) without overcommitting to the bear case by selling at lower Bollinger support after one quarter of doubt. The trader's full liquidation at $396 replicates the trim-into-support errors flagged in prior reflections; the Conservative's reactive-only framework crystallizes losses before protective action. The event-driven re-entry mechanism (50 SMA reclaim with volume + MACD positive, OR Q3 operating margin >7% with constructive MLR, OR favorable IRS resolution) ties future action to confirmable signals rather than predetermined prices, avoiding both failure modes: permanently selling 20-40% at a discount that didn't materialize, or giving up participation in a non-range-bound scenario with 32% Fed hike probability and unresolved binary catalysts. The 200 SMA at $346 remains the hard structural floor and preferred re-entry zone on any flush with volume climax.
| Position | Action |
|---|---|
| Trim 15-20% of position | Sell down at $393-396 |
| Residual tranche after trim | Maintain 80-85% core position |
| Hedge mandatory on residual | Pre-committed Dec 2026 put spread at 25% of residual, sized to AEP-proximity (Q3 print mid-October) |
| Residual tranche technical breakdown | $382 closing-basis stop on expanding volume |
UNH's technical weakness is a coiled spring masking genuine earnings recovery; Q1 2026 confirmed margin expansion, cash generation, and debt reduction at a reasonable 17.7x forward P/E, making this a generational entry point before October's Star Ratings catalyst.
| Indicator | Value | Signal |
|---|---|---|
| Close | $396.59 | neutral |
| 10 EMA | $396.56 | neutral |
| 20 SMA (Bollinger Middle) | $403.45 | bearish |
| 50 SMA | $413.42 | bearish |
| 200 SMA | $346.06 | bullish |
| RSI | 44.19 | neutral |
| MACD | –6.24 | bearish |
| MACD Signal | –5.41 | bearish |
| MACD Histogram | –0.84 | neutral |
| Bollinger Upper Band | $424.06 | bearish |
| Bollinger Lower Band |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 earnings showing sustained operating margin >7% with constructive commercial MLR commentary
Then: Re-enter trimmed portion
Valuation is reasonable at 17.7x forward P/E for a company in earnings recovery — forward P/E compresses to 14.4x on Q1 annualized
↩ rebuts: “Bear focus on 2025's 41.3% operating income decline and 16.3% net income decline as if still being printed today”
EV: +$13.2% to +24.5% · concedes: Commercial book cost trend remains unresolved at the SG&A level (operating expenses +12.1%); IRS transfer-pricing dispute has undisclosed magnitude and could extend 3–5 years; Forward EPS $22.44 requires 69.6% jump from 2025; Q4 2025 anomaly must normalize; Technical resistance at $413.42 (50 SMA) is real overhead supply
The current dip in UNH is a value trap built on a single quarter of gross margin discipline that masks accelerating operating expense growth, a structurally deteriorating balance sheet with negative tangible equity, an unpriced IRS transfer-pricing overhang, and a commercial cost trend that has not inflected—all requiring heroic forward EPS assumptions that leave the stock with asymmetric downside risk to $310-320 if estimates get cut.
EV: -$346 (T3: 200 SMA), with downside risk to $310-$320 (T4) if commercial cost trend fails to inflect by Q3 earnings · concedes: MACD histogram did contract from -2.80 to -0.84 (momentum is decelerating); Net debt did fall 7.6% in Q1 2026 (though from one-quarter working capital release); Gross margin did show some discipline at Q1 level; Institutional flow angle is genuinely interesting as a long-term signal; Q2-Q4 2025 EPS of $6.34 combined was indeed depressed by comparison base
→ vs conservative: Zacks triple-listing on August 21st was a lazy conviction signal fired after the stock had already ripped; the 80% off-bottom framing is a psychological trap that doesn't validate the forward EPS path
→ vs conservative: The 70% EPS growth requirement from 13.23 to 22.44 is unrealistic—Q2-Q4 2025 averaged only 2.11 per quarter versus the run-rate needed
→ vs conservative: Owning 100% of a position when price is 14% below the 50 SMA with confirmed MACD sell signal and structural margin question is not prudent risk management
→ vs neutral: 'Wait for confirmation' is a license to do nothing while the stock bleeds through an entire quarter of known headwinds (IRS transfer-pricing, medical cost trends, Aon 9.5% cost inflation, 32% rate hike probability)
→ vs neutral: The neutral plan provides no cash to redeploy if the stock breaks down below 396; both conservative and neutral are making a binary bet that the stock holds with no optionality
| $382.84 |
| bullish |
| ATR (14-day) | $9.56 | neutral |
| VWMA | $398.43 | bearish |
Support: 382.84 · 388 · 390 · 346.06 | Resistance: 424.06 · 413.42 · 436.35
UNH exhibits a mixed technical picture: long-term trend remains bullish (price above 200 SMA, ATR compressed at $9.56 suggesting coiling), but short-term indicators are bearish (price below 10 EMA and 50 SMA, MACD negative). Early bullish divergence in RSI and MACD histogram contraction suggest potential momentum exhaustion. Key levels to watch: resistance at $413–$424, support at $383–$390. Final recommendation is HOLD—existing long-term positions should be maintained while awaiting confirmation above $403–$413 or a deeper pullback to $346–$365 for higher-conviction entries.
Market Capitalization
$355.98 billion
Market Cap (implied price basis)
$396.59 per share
Vendor TTM P/E
25.50
Forward P/E
17.68
Vendor Forward P/E
17.677
PEG Ratio
1.20
Price-to-Book
3.65
Price-to-Book (vendor)
3.646
Dividend Yield
2.33%
Beta
0.632
Book Value Per Share
$108.78
52-Week High
$461.62
52-Week Low
$255.97
50-Day Average
$413.66
200-Day Average
$348.33
2022 Revenue
$324.162 billion
2023 Revenue
$371.622 billion
2024 Revenue
$400.278 billion
2025 Revenue
$447.567 billion
2025 Revenue Growth
11.8%
2022 Gross Profit
$79.617 billion
2023 Gross Profit
$90.958 billion
2024 Gross Profit
$89.399 billion
2025 Gross Profit
$82.917 billion
2022 Gross Margin
24.6%
2023 Gross Margin
24.5%
2024 Gross Margin
22.3%
2025 Gross Margin
18.5%
2022 Operating Income
$28.435 billion
2023 Operating Income
$32.358 billion
2024 Operating Income
$32.287 billion
2025 Operating Income
$18.964 billion
2025 Operating Income Change
-41.3%
2022 Operating Margin
8.8%
2023 Operating Margin
8.7%
2024 Operating Margin
8.1%
2025 Operating Margin
4.2%
2022 EBITDA
$31.835 billion
2023 EBITDA
$36.330 billion
2024 EBITDA
$28.076 billion
2025 EBITDA
$23.060 billion
2022 Net Income
$20.120 billion
2023 Net Income
$22.381 billion
2024 Net Income
$14.405 billion
2025 Net Income
$12.056 billion
2025 Net Income Change
-16.3%
2022 Net Margin
6.2%
2023 Net Margin
6.0%
2024 Net Margin
3.6%
2025 Net Margin
2.7%
2022 Diluted EPS
$21.18
2023 Diluted EPS
$23.86
2024 Diluted EPS
$15.51
2025 Diluted EPS
$13.23
2025 Diluted EPS Change
-14.7%
2022 Operating Cash Flow
$26.206 billion
2023 Operating Cash Flow
$29.068 billion
2024 Operating Cash Flow
$24.204 billion
2025 Operating Cash Flow
$19.697 billion
2022 Free Cash Flow
$23.404 billion
2023 Free Cash Flow
$25.682 billion
2024 Free Cash Flow
$20.705 billion
2025 Free Cash Flow
$16.075 billion
2025 Free Cash Flow Change
-22.4%
2022 Net Debt
$34.258 billion
2023 Net Debt
$37.110 billion
2024 Net Debt
$51.592 billion
2025 Net Debt
$54.024 billion
Q1 2025 Revenue
$109.575 billion
Q1 2026 Revenue
$111.721 billion
Q1 2026 Revenue Growth
2.0%
Q1 2025 Cost of Revenue
$85.801 billion
Q1 2026 Cost of Revenue
$86.312 billion
Q1 2026 Cost of Revenue Growth
0.6%
Q1 2025 Gross Profit
$23.774 billion
Q1 2026 Gross Profit
$25.409 billion
Q1 2026 Gross Profit Growth
6.9%
Q1 2025 Gross Margin
21.7%
Q1 2026 Gross Margin
22.7%
Q1 2025 Operating Income
$9.119 billion
Q1 2026 Operating Income
$8.990 billion
Q1 2026 Operating Income Change
-1.4%
Q1 2025 Operating Margin
8.32%
Q1 2026 Operating Margin
8.05%
Q1 2025 EBITDA
$10.165 billion
Q1 2026 EBITDA
$9.947 billion
Q1 2026 EBITDA Change
-2.1%
Q1 2025 Net Income
$6.292 billion
Q1 2026 Net Income
$6.280 billion
Q1 2026 Net Income Change
-0.2%
Q1 2025 Net Margin
5.74%
Q1 2026 Net Margin
5.62%
Q1 2025 Diluted EPS
$6.85
Q1 2026 Diluted EPS
$6.90
Q1 2026 Diluted EPS Change
0.7%
Q1 2025 Diluted Shares
918 million
Q1 2026 Diluted Shares
910 million
Q1 2026 Diluted Shares Change
-0.9%
Q1 2025 Operating Cash Flow
$5.456 billion
Q1 2026 Operating Cash Flow
$8.912 billion
Q1 2026 Operating Cash Flow Growth
63.3%
Q1 2025 Free Cash Flow
$4.558 billion
Q1 2026 Free Cash Flow
$8.149 billion
Q1 2026 Free Cash Flow Growth
78.8%
Q1 2025 Free Cash Flow Margin
4.16%
Q1 2026 Free Cash Flow Margin
7.29%
Q1 2026 Operating Expense Growth
12.1%
Total Assets
$312.64 billion
Total Debt
$77.92 billion
Cash and Equivalents
$28.00 billion
Cash and Short-Term Investments
$31.23 billion
Net Debt
$49.92 billion
Q1 2026 Net Debt Change
-7.6%
Q1 2026 Cash Change
14.9%
Common Equity
$97.88 billion
Total Equity
$105.32 billion
Current Assets
$91.13 billion
Current Liabilities
$114.12 billion
Working Capital Deficit
$23.00 billion
Working Capital Improvement
$1.32 billion
Long-Term Debt
$71.44 billion
Current Debt
$6.48 billion
Goodwill and Intangibles
$130.61 billion
Goodwill
$110.51 billion
Intangibles as % of Assets
41.8%
Intangibles to Common Equity
1.33 times
Tangible Book Value
-$32.72 billion
Current Ratio
0.80
Cash to Current Debt Ratio
4.3 times
Cash plus Short-Term to Current Debt
4.8 times
Net Debt to EBITDA (statement-derived)
2.2 times
2025 Interest Expense
$4.00 billion
2024 Interest Expense
$3.91 billion
2025 Interest Coverage
4.7 times
Q1 2026 Interest Coverage
9.4 times
2025 Capital Expenditure
$3.62 billion
2025 Dividends
$7.92 billion
2025 Share Repurchases
$5.55 billion
2025 Acquisition Spending
$4.51 billion
2025 Net Debt Issuance
$0.73 billion
2025 Total Shareholder Returns
$13.46 billion
FCF to Shareholder Returns Ratio
83.8%
Q1 2026 Working Capital Contribution
$746 million
Q1 2025 Working Capital Impact
-$2.63 billion
Working Capital Swing
$3.38 billion
Q1 2026 Cash Increase
$3.47 billion
Q1 2026 Dividends Paid
$2.01 billion
2022 Year-End Shares
934 million
2023 Year-End Shares
924 million
2024 Year-End Shares
915 million
2025 Year-End Shares
905.84 million
Q1 2026 Shares
907.68 million
Share Count Reduction 2022-2025
3%
Q1 2026 Sequential Share Increase
0.2%
Vendor TTM Revenue
$450.53 billion
Statement-Derived TTM Revenue
$449.71 billion
Statement-Derived TTM Gross Profit
$84.55 billion
Statement-Derived TTM Operating Income
$18.84 billion
Statement-Derived TTM EBITDA
$22.84 billion
Statement-Derived TTM Net Income
$12.04 billion
Statement-Derived TTM Free Cash Flow
$19.67 billion
Vendor TTM EBITDA
$26.68 billion
Vendor TTM Net Income
$14.12 billion
Vendor TTM Free Cash Flow
$24.27 billion
TTM Diluted EPS (statement-derived)
$13.28
TTM EPS at Current Price
29.9 times
Price-to-Free-Cash-Flow
18.3 times
Forward EPS Estimate
$22.44
Forward EPS vs TTM EPS
44.3%
Forward EPS vs 2025 EPS
69.6%
Q1 Annualized EPS
$27.60
Q2-Q4 2025 Combined EPS
$6.34
Vendor FCF Yield
6.8%
2025 Effective Tax Rate
12.9%
2024 Effective Tax Rate
24.1%
Revenue CAGR 2022-2025
11.4%
Net Income Decline CAGR
-15.8%
Free Cash Flow Decline CAGR
-11.8%
Net Debt Growth CAGR
16.5%
2025 Cost of Revenue Increase
17.3%
2025 Gross Profit Decline
7.2%
2025 Operating Expense Increase
12.0%
2024 Unusual Item
$8.31 billion
2024 Normalized Income
$20.71 billion
2025 Normalized Income
$12.29 billion
Payables and Accrued Expenses
$78.29 billion
Payables as % of Current Liabilities
68.6%
Common Equity Change
4.0%
Distance from 50-day Average
-4.1%
Distance from 200-day Average
13.8%
Distance from 52-week High
-14.1%
Distance from 52-week Low
55.0%
Bull Case Value (EPS $22.44, 20x)
$449
Bear Case Value (EPS $18, 18x)
$324
Recommended Entry Price
$380
Recommended Entry Forward P/E
16.9 times
Strengths
Concerns
UNH faces a challenging fundamental environment where 2025 saw operating income collapse 41.3% and gross margin contract 381 basis points to 18.5%, despite 11.8% revenue growth, with diluted EPS falling to $13.23. Q1 2026 shows early recovery signs including 105 basis points of gross margin improvement and 78.8% free cash flow growth to $8.15 billion, but operating income still declined 1.4% and the forward EPS target of $22.44 requires a 69.6% recovery that appears dependent on seasonal factors and cost controls that remain unproven. The balance sheet presents structural concerns with negative tangible book value, working capital deficit, and goodwill exceeding common equity, though net debt declined $4.11 billion sequentially in Q1 2026. HOLD is recommended as the valuation at approximately $397 implies 29.9 times trailing earnings and requires sustained margin recovery above 7% with free cash flow near $20 billion annually to justify the forward multiple.
Macro: Fed policy is the dominant macro signal: hawkish surprise is priced into September 2026 FOMC (+25 bps hike at 32%, rising fast from 28% a week prior), and 'no Fed cuts in 2026' is priced at 86%. This removes the discount-rate tailwind from defensive GARP names. Recession risk is benign (8% U.S. by end-2026), supporting stable enrollment in UNH's commercial and MA books. Consumer weakness signals from Walmart, Nike, and Disney reinforce UNH's defensive positioning and may help contain wage-driven medical-cost inflation — a nuanced bull factor that offsets part of Aon's 9.5% employer healthcare cost forecast for 2027.